To comply with the updates made by the American Medical Association, effective July 1, 2026, we’ll add new procedure codes to our prior authorization requirements for genetic and molecular testing. This change applies to certain UnitedHealthcare commercial plans and UnitedHealthcare Individual Exchange Plans.
This change affects the following plans in all states:
In addition to the current in-scope procedure codes, we’ll add the following codes to the existing prior authorization/advance notification requirements:
For more information, view our genetic and molecular testing resources.
Connect with us through chat 24/7 in the UnitedHealthcare Provider Portal.
PCA-1-26-00439-Clinical-NN_03052026